You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Correction: Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1

https://doi.org/10.1136/jitc-2020-001698corr2

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Yin Z, Yu M, Ma T, et al. Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. J ImmunoTher Cancer 2021;9:e001698. doi: 10.1136/jitc-2020-001698

    This article has been corrected since it was first published. Amir Abaas Momtazi-Borojeni’s affiliation has been updated to ‘Department of Medical Biotechnology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran’.